Genentech

This year’s National Tribal Health Conference offered powerful insight into what’s ahead for Indigenous health – shaped by sovereignty, driven by culture and sustained through partnership. Thank you, ASU College of Health Solutions and National Indian Health Board for welcoming us into this meaningful space and spotlighting how the community-driven programs supported by our Innovation Fund are transforming health outcomes for Indigenous communities. We look forward to continuing to work alongside Tribal leaders and partners in this vital work. Learn more about ASU's work to advance healthcare access and outcomes for Indigenous communities here: http://spr.ly/6049AcvWP Pictured: Photo 1: Dr. John Molina, Director of the Arizona Advisory Council on Indian Health Care, greets a guest at the National Indian Health Board’s Gala – “Voices of Our Tribes” Photo 2: ASU colleagues, alumni, and community leaders gather to celebrate at the National Indian Health Board’s Gala – “Voices of Our Tribes” Photo 3: Dr. Angela Gonzales, Director & Professor of American Indian Studies, presents on ASU’s Indigenous Health Initiative at the National Indian Health Board’s 2025 National Tribal Health Conference

The FDA approved our new treatment regimen for extensive-stage small cell #LungCancer (ES-SCLC). Learn more about the first and only combination therapy approved for first-line maintenance treatment of ES-SCLC, an aggressive and difficult to treat form of lung cancer: http://spr.ly/6047AcfbR

#LupusNephritis is a serious and often underrecognized manifestation of lupus that can lead to lasting kidney damage. The challenge is that symptoms can be subtle or easily missed, leading to delays in diagnosis when time matters the most. Earlier recognition can make a significant difference in improving long-term outcomes for patients. We're working to advance education and awareness to help healthcare providers and patients recognize the signs sooner and make more informed care decisions.

Congratulations to Aviv Regev, Head of our Research and Early Development organization, whose contributions to the field of immunology have been recognized by the Cancer Research Institute (CRI). CRI has selected Aviv as a 2025 William B. Coley Award recipient, citing the transformative impact of Aviv’s application of single-cell genomics and computational biology on our understanding of the immune system. These discoveries have illuminated promising new avenues for immunotherapy and precision medicine.

And that’s a wrap on #ECTRIMS2025! At this year’s congress, we presented new data from our multiple sclerosis (MS) portfolio, highlighting our dedication to preventing disability progression for a broad population of people living with MS. Hear from attendees including patient advocates, healthcare professionals and our Genentech team about this year's ECTRIMS.

Visualizing small proteins – a crucial part of understanding disease drivers – has long been one of the toughest challenges in cryo-electron microscopy. Our scientists have overcome this obstacle by developing “Rigid Fabs,” a groundbreaking innovation which can transform antibody fragments into rigid scaffolds, making it possible to capture high-resolution images of small proteins. The video shows we are able to resolve small proteins to high resolution by cryoEM using our newly developed technology. Read more about this advancement in Nature Communications to learn how this technology is paving the way for accelerated drug discovery. http://spr.ly/6040A9no6

Congratulations to Dr. Sandra Milan, Vice President, Genentech Research and Early Development, on her recent appointment to the Congressional Hispanic Caucus Institute (CHCI) Advisory Council. This recognition is a true testament of her outstanding leadership and commitment to driving more equitable healthcare and clinical research. We’re thrilled that Dr. Milan will bring her expertise and passion to this role to help drive community-centered solutions and nurture the next generation of leaders. Learn more about CHCI: http://spr.ly/6041AgD2v Pictured: Dr. Milan (left) standing next to Quita Highsmith (right), Vice President, Population Health Center of Excellence, at last year’s CHCI Gala.

From designing more inclusive clinical trials to shaping policy solutions that support equitable access, our hematology team is working side-by-side with community oncologists, industry experts, and advocates to meet blood cancer patients where they are. Tony Lin, our Vice President and Therapeutic Area Head, Oncology & Hematology, shares how the future of #hematology is being shaped by innovation and collaboration to advance care for people living with hematologic disorders. #BloodCancerAwarenessMonth #CommunityOncology #BloodCancer

Take a closer look hashtag #IntheLab at how scientists like Eleonore Tham are developing cell therapies—treatments that reprogram cells to detect and fight disease. From editing a single cell to scaling it into billions, these breakthroughs are paving the way for smarter, more precise medicines. See the science in action and learn more in the latest episode of Two Scientists Walk Into a Bar. https://lnkd.in/ej_-Dt28

Multiple sclerosis (MS) affects about 1M people in the U.S., and while symptoms vary from person to person – often progressing quietly over time – it can impact nearly every part of the body and the mind. Hear from Dr. Oh about how we can look at MS as one disease, and how staying ahead of disease progression starts with informed, ongoing discussions. Explore resources for navigating conversations here: http://spr.ly/6045Aw8Iz